SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis

被引:73
作者
Cronin, Julia C. [1 ]
Watkins-Chow, Dawn E. [1 ]
Incao, Art [1 ]
Hasskamp, Joanne H. [2 ]
Schoenewolf, Nicola [3 ]
Aoude, Lauren G. [4 ]
Hayward, Nicholas K. [4 ]
Bastian, Boris C. [5 ]
Dummer, Reinhard [3 ]
Loftus, Stacie K. [1 ]
Pavan, William J. [1 ]
机构
[1] NHGRI, Genet Dis Res Branch, Bethesda, MD 20892 USA
[2] Medstar Franklin Sq Med Ctr, Maryland Melanoma Ctr, Baltimore, MD USA
[3] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[4] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia
[5] UCSF, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
基金
英国医学研究理事会;
关键词
LINEAGE SURVIVAL; MITF; MUTATIONS; EXPRESSION; MOUSE; ACTIVATION; GENE; DEGRADATION; MELANOCYTES; INHIBITION;
D O I
10.1158/0008-5472.CAN-12-4620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The transcription factor SOX10 is essential for survival and proper differentiation of neural crest cell lineages, where it plays an important role in the generation and maintenance of melanocytes. SOX10 is also highly expressed in melanoma tumors, but a role in disease progression has not been established. Here, we report that melanoma tumor cell lines require wild-type SOX10 expression for proliferation and SOX10 haploinsufficiency reduces melanoma initiation in the metabotropic glutamate receptor 1 (Grm1(Tg)) transgenic mouse model. Stable SOX10 knockdown in human melanoma cells arrested cell growth, altered cellular morphology, and induced senescence. Melanoma cells with stable loss of SOX10 were arrested in the G(1) phase of the cell cycle, with reduced expression of the melanocyte determining factor microphthalmia-associated transcription factor, elevated expression of p21WAF1 and p27KIP2, hypophosphorylated RB, and reduced levels of its binding partner E2F1. As cell-cycle dysregulation is a core event in neoplastic transformation, the role for SOX10 in maintaining cell-cycle control in melanocytes suggests a rational new direction for targeted treatment or prevention of melanoma. (C) 2013 AACR.
引用
收藏
页码:5709 / 5718
页数:10
相关论文
共 47 条
[1]   SOX10 expression in superficial spreading and nodular malignant melanomas [J].
Agnarsdottir, Margret ;
Sooman, Linda ;
Bolander, Asa ;
Stromberg, Sara ;
Rexhepaj, Elton ;
Bergqvist, Michael ;
Ponten, Fredrik ;
Gallagher, William ;
Lennartsson, Johan ;
Ekman, Simon ;
Uhlen, Mathias ;
Hedstrand, Hakan .
MELANOMA RESEARCH, 2010, 20 (06) :468-478
[2]   BRAF Inhibitors for the Treatment of Metastatic Melanoma: Clinical Trials and Mechanisms of Resistance [J].
Alcala, Alexander Marzuka ;
Flaherty, Keith T. .
CLINICAL CANCER RESEARCH, 2012, 18 (01) :33-39
[3]   Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma [J].
Bakos, Renato M. ;
Maier, Tanja ;
Besch, Robert ;
Mestel, Dominik S. ;
Ruzicka, Thomas ;
Sturm, Richard A. ;
Berking, Carola .
EXPERIMENTAL DERMATOLOGY, 2010, 19 (08) :E89-E94
[4]   Melanoma genome sequencing reveals frequent PREX2 mutations [J].
Berger, Michael F. ;
Hodis, Eran ;
Heffernan, Timothy P. ;
Deribe, Yonathan Lissanu ;
Lawrence, Michael S. ;
Protopopov, Alexei ;
Ivanova, Elena ;
Watson, Ian R. ;
Nickerson, Elizabeth ;
Ghosh, Papia ;
Zhang, Hailei ;
Zeid, Rhamy ;
Ren, Xiaojia ;
Cibulskis, Kristian ;
Sivachenko, Andrey Y. ;
Wagle, Nikhil ;
Sucker, Antje ;
Sougnez, Carrie ;
Onofrio, Robert ;
Ambrogio, Lauren ;
Auclair, Daniel ;
Fennell, Timothy ;
Carter, Scott L. ;
Drier, Yotam ;
Stojanov, Petar ;
Singer, Meredith A. ;
Voet, Douglas ;
Jing, Rui ;
Saksena, Gordon ;
Barretina, Jordi ;
Ramos, Alex H. ;
Pugh, Trevor J. ;
Stransky, Nicolas ;
Parkin, Melissa ;
Winckler, Wendy ;
Mahan, Scott ;
Ardlie, Kristin ;
Baldwin, Jennifer ;
Wargo, Jennifer ;
Schadendorf, Dirk ;
Meyerson, Matthew ;
Gabriel, Stacey B. ;
Golub, Todd R. ;
Wagner, Stephan N. ;
Lander, Eric S. ;
Getz, Gad ;
Chin, Lynda ;
Garraway, Levi A. .
NATURE, 2012, 485 (7399) :502-506
[5]  
Bernex F, 1996, DEVELOPMENT, V122, P3023
[6]  
Boyer SN, 1996, CANCER RES, V56, P4620
[7]   The transcription factor Sox10 is a key regulator of peripheral glial development [J].
Britsch, S ;
Goerich, DE ;
Riethmacher, D ;
Peirano, RI ;
Rossner, M ;
Nave, KA ;
Birchmeier, C ;
Wegner, M .
GENES & DEVELOPMENT, 2001, 15 (01) :66-78
[8]   Genetic and morphologic features for melanoma classification [J].
Broekaert, Sigrid M. C. ;
Roy, Ritu ;
Okamoto, Ichiro ;
van den Oord, Joost ;
Bauer, Juergen ;
Garbe, Claus ;
Barnhill, Raymond L. ;
Busam, Klaus J. ;
Cochran, Alistair J. ;
Cook, Martin G. ;
Elder, David E. ;
McCarthy, Stanley W. ;
Mihm, Martin C. ;
Schadendorf, Dirk ;
Scolyer, Richard A. ;
Spatz, Alan ;
Bastian, Boris C. .
PIGMENT CELL & MELANOMA RESEARCH, 2010, 23 (06) :763-770
[9]   Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression [J].
Carreira, S ;
Goodall, J ;
Aksan, I ;
La Rocca, SA ;
Galibert, MD ;
Denat, L ;
Larue, L ;
Goding, CR .
NATURE, 2005, 433 (7027) :764-769
[10]   Mitf regulation of Dia1 controls melanoma proliferation and invasiveness [J].
Carreira, Suzanne ;
Goodall, Jane ;
Denat, Laurence ;
Rodriguez, Mercedes ;
Nuciforo, Paolo ;
Hoek, Keith S. ;
Testori, Alessandro ;
Larue, Lionel ;
Goding, Colin R. .
GENES & DEVELOPMENT, 2006, 20 (24) :3426-3439